Miao Jing, Lesher Allison M, Miwa Takashi, Sato Sayaka, Gullipalli Damodar, Song Wen-Chao
Department of Pharmacology and Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Kidney Int. 2014 Oct;86(4):726-37. doi: 10.1038/ki.2014.103. Epub 2014 May 21.
The murine cell surface protein Crry (complement receptor 1-related protein/gene y) is a key complement regulator with similar activities to human membrane cofactor protein (MCP) and decay-accelerating factor. MCP has a critical role in preventing complement-mediated tissue injury and its mutation has been implicated in several human kidney diseases. The study of Crry in mice has relevance to understanding MCP activity in human diseases; however, such efforts have been hampered by the embryonic lethality phenotype of Crry gene knockout. Here we used a conditional gene-targeting approach and deleted Crry from the mouse proximal tubular epithelial cells where Crry is prominently expressed. Absence of Crry from proximal tubular epithelial cells resulted in spontaneous C3 deposition on the basolateral surface but no apparent renal disease in unchallenged mice. However, mice deficient in Crry on proximal tubular epithelial cells developed exacerbated renal injury when subjected to renal ischemia-reperfusion, showing increased blood urea nitrogen levels, higher tubular injury scores, more tubular epithelial cell apoptosis, and inflammatory infiltrates. Renal ischemia-reperfusion injury in the Crry conditional knockout mice was prevented by blocking C3 and C5 activation using an anti-properdin or anti-C5 monoclonal antibody (mAb), respectively. Thus, Crry has a critical role in protecting proximal tubular epithelial cells during ischemia-reperfusion challenge. Our results highlight the latent risk for inflammatory kidney injury associated with defects in membrane complement regulators.
小鼠细胞表面蛋白Crry(补体受体1相关蛋白/基因y)是一种关键的补体调节因子,其活性与人膜辅助蛋白(MCP)和衰变加速因子相似。MCP在预防补体介导的组织损伤中起关键作用,其突变与几种人类肾脏疾病有关。对小鼠中Crry的研究与理解人类疾病中MCP的活性相关;然而,此类研究因Crry基因敲除的胚胎致死表型而受阻。在此,我们采用条件性基因靶向方法,从小鼠近端肾小管上皮细胞中删除Crry,Crry在该细胞中显著表达。近端肾小管上皮细胞中缺乏Crry导致基底外侧表面自发沉积C3,但在未受刺激的小鼠中未出现明显的肾脏疾病。然而,近端肾小管上皮细胞中缺乏Crry的小鼠在遭受肾脏缺血再灌注时,肾损伤加剧,表现为血尿素氮水平升高、肾小管损伤评分更高、肾小管上皮细胞凋亡增多以及炎症浸润。分别使用抗备解素或抗C5单克隆抗体(mAb)阻断C3和C5激活,可预防Crry条件性敲除小鼠的肾脏缺血再灌注损伤。因此,Crry在缺血再灌注应激期间对保护近端肾小管上皮细胞起关键作用。我们的结果突出了与膜补体调节因子缺陷相关的炎症性肾损伤的潜在风险。